Literature DB >> 918904

Simple, sensitive fluorimetric assay for malondialdehyde production by blood platelets.

R M McMillan, D E MacIntyre, J L Gordon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 918904     DOI: 10.1016/0049-3848(77)90194-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  9 in total

1.  Biochemical mechanisms in 5-hydroxytryptamine-induced human platelet aggregation.

Authors:  F de Clerck; B Xhonneux; R van de Wiele
Journal:  Agents Actions       Date:  1985-12

2.  Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.

Authors:  F de Clerck; J L David; P A Janssen
Journal:  Agents Actions       Date:  1994-12

3.  High dose gammaglobulin therapy in adults with idiopathic thrombocytopenic purpura (ITP). Clinical effects.

Authors:  R E Schmidt; U Budde; C Bröschen-Zywietz; G Schäfer; C Mueller-Eckhardt
Journal:  Blut       Date:  1984-01

Review 4.  Effect of heparin and heparin fractions on platelet aggregation.

Authors:  E W Salzman; R D Rosenberg; M H Smith; J N Lindon; L Favreau
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

5.  Changes in thrombin-stimulated platelet malondialdehyde production during the menstrual cycle.

Authors:  H Tindall; M Zuzel; R C Paton; G P McNicol
Journal:  J Clin Pathol       Date:  1981-06       Impact factor: 3.411

6.  Malonaldehyde formation in intact platelets is catalysed by thromboxane synthase.

Authors:  R M McMillan; D E MacIntyre; A Booth; J L Gordon
Journal:  Biochem J       Date:  1978-11-15       Impact factor: 3.857

7.  Lipid peroxidation in normal and ulcerated gastric mucosa of rats treated with pentacaine and cimetidine.

Authors:  V Nosálová; M Petríková; R Nosál
Journal:  Agents Actions       Date:  1989-04

8.  Platelet-vessel wall interactions in hemostasis: implication of 5-hydroxytryptamine.

Authors:  F De Clerck; Y Somers; L Van Gorp
Journal:  Agents Actions       Date:  1984-12

9.  Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.

Authors:  F de Clerck; J L David; P A Janssen
Journal:  Agents Actions       Date:  1982-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.